Aree Pantusart

Summary

Publications

  1. ncbi request reprint Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital
    Jiraprapa Natee
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 7:234-8. 2006
  2. ncbi request reprint Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance
    Bandit Chumworathayi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
    J Med Assoc Thai 88:1483-92. 2005
  3. ncbi request reprint Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    J Med Assoc Thai 88:1338-43. 2005
  4. ncbi request reprint Appropriate interval for repeat excision in women undergoing prior loop electrosurgical excision procedure for cervical neoplasia
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 8:379-82. 2007
  5. ncbi request reprint Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial
    Charuwan Tantipalakorn
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, 50200 Thailand
    J Med Assoc Thai 87:119-25. 2004

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital
    Jiraprapa Natee
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 7:234-8. 2006
    ..The prognosis of patients with these tumors appears excellent...
  2. ncbi request reprint Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance
    Bandit Chumworathayi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
    J Med Assoc Thai 88:1483-92. 2005
    ..To compare weekly and three-weekly cisplatin as an adjunct to radiation therapy in high-risk early-stage cervical cancer after surgery with regard to treatment compliance...
  3. ncbi request reprint Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    J Med Assoc Thai 88:1338-43. 2005
    ..To analyze the clinicopathologic features of women with primary fallopian tube carcinoma..
  4. ncbi request reprint Appropriate interval for repeat excision in women undergoing prior loop electrosurgical excision procedure for cervical neoplasia
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 8:379-82. 2007
    ..In conclusion, repeat LEEP could be safely performed 4-12 weeks after the first procedure without any impact on pathological specimen examination...
  5. ncbi request reprint Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial
    Charuwan Tantipalakorn
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, 50200 Thailand
    J Med Assoc Thai 87:119-25. 2004
    ..To compare the antiemetic efficacy of a single oral versus intravenous (i.v.) ramosetron, a new class of selective 5-HT3 receptor antagonists, in gynecologic cancer patients receiving high-dose cisplatin...